Seeing Is Believing
Currently out of the existing stock ratings of Andrew Mok, 38 are a SELL (10.53%), 128 are a HOLD (35.46%), 195 are a BUY (54.02%).
Analyst Andrew Mok, currently employed at BARCLAYS, carries an average stock price target met ratio of 60.55% that have a potential upside of 15.95% achieved within 138 days.
Andrew Mok’s has documented 723 price targets and ratings displayed on 32 stocks. The coverage is on Healthcare, Industrials sectors.
Most recent stock forecast was given on HUM, Humana.
Analyst best performing recommendations are on AGL (AGILON HEALTH).
The best stock recommendation documented was for DVA (DAVITA HEALTHCARE PARTNERS) at 2/2/2026. The price target of $143 was fulfilled within 3 days with a profit of $31.81 (28.61%) receiving and performance score of 95.36.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 21-Feb-2023
$100
$-0.99 (-0.98%)
$100
1 years 5 months 24 days ago
(16-Apr-2025)
2/3 (66.67%)
$8.09 (8.80%)
307
Hold Since 21-Apr-2023
$101
$0.01 (0.01%)
$101
1 years 6 months 6 days ago
(04-Apr-2025)
2/10 (20%)
$9.11 (9.91%)
419
Hold Since 26-Mar-2024
1 years 7 months ago
(10-Mar-2025)
6/11 (54.55%)
$12.13 (9.49%)
97
Hold Since 22-Oct-2019
$101
$0.01 (0.01%)
$103
1 years 7 months 6 days ago
(04-Mar-2025)
4/11 (36.36%)
$8.9 (9.66%)
18
Buy Since 03-Aug-2018
$100
$-0.99 (-0.98%)
$139
1 years 9 months 10 days ago
(30-Dec-2024)
8/14 (57.14%)
$9.51 (10.51%)
89
Which stock is Andrew Mok most bullish on?
Which stock is Andrew Mok most reserved on?
What Year was the first public recommendation made by Andrew Mok?